Current limitations in treatment of heart failure: New avenues and treatment options

Journal of Cardiovascular Electrophysiology

Volumn 13, Issue 1 SUPPL., 2002, Pages

  Drexler, Helmut ^a   Fuchs, Martin ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Calcium homeostasis; Cytokine; Energy depletion; Heart failure; Sudden cardiac death

Indexed keywords

AMIODARONE; ANGIOTENSIN; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ION; CARVEDILOL; CATECHOLAMINE; CYTOKINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ENDOTHELIN; GLYCOPROTEIN GP 130; INTERLEUKIN 6; SODIUM CALCIUM EXCHANGE PROTEIN; SPIRONOLACTONE; TUMOR NECROSIS FACTOR ALPHA;

CALCIUM HOMEOSTASIS; CAUSE OF DEATH; CLINICAL TRIAL; CONFERENCE PAPER; DISEASE COURSE; DRUG EFFECT; DRUG EFFICACY; ENERGY; HEART FAILURE; HUMAN; NEUROENDOCRINE SYSTEM; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SURVIVAL RATE; SYMPTOM; WESTERN HEMISPHERE;

EID: 0036152651     PISSN: 10453873     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1540-8167.2002.tb01954.x     Document Type: Conference Paper

References (26)

1. The effect of spironolactone on morbidity and mortality in patients with severe heart failure
2. Endothelin and endothelin receptor antagonism in heart failure
3. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease
4. Explaining fatigue in congestive heart failure
5. Elevated circulating levels of tumor necrosis factor in severe chronic heart failure
6. Tumor necrosis factor-alpha and tumor necrosis factor receptors in the failing human heart
7. Hemodynamic regulation of tumor necrosis factor-alpha gene and protein expression in adult feline myocardium
8. Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha
9. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure
10. Interleukin-6 spillover in the peripheral circulation increases with the severity of heart failure, and the high plasma level of interleukin-6 is an important prognostic predictor in patients with congestive heart failure
11. The role of interleukin-6 in the failing heart
12. Negative inotropic effects of cytokines on the heart mediated by nitric oxide
13. Continuous activation of gp130, a signal-transducing receptor component for interleukin 6-related cytokines, causes myocardial hypertrophy in mice
14. Cardiac myocytes produce interleukin-6 in culture and in viable border zone of reperfused infarctions
15. Cytokine gene expression after myocardial infarction in rat hearts: Possible implication in left ventricular remodeling
16. Hypoxic stress induces cardiac myocyte-derived interleukin-6
17. Cytokine expression increases in nonmyocytes from rats with postinfarction heart failure
18. Activation of JAK/STAT pathway transduces cytoprotective signal in rat acute myocardial infarction
19. Loss of a gp130 cardiac muscle cell survival pathway is a critical event in the onset of heart failure during biomechanical stress
20. Calcium cycling proteins and force-frequency relationship in heart failure
21. Adenoviral gene transfer of SERCA2a improves left-ventricular function in aortic-banded rats in transition to heart failure
22. Restoration of contractile function in isolated cardiomyocytes from failing human hearts by gene transfer of SERCA2a
23. Phospholamban and cardiac contractility
24. Chronic phospholamban-sarcoplasmic reticulum calcium ATPase interaction is the critical calcium cycling defect in dilated cardiomyopathy
25. Effects of early angiotensin-converting enzyme inhibition on cardiac gene expression after acute myocardial infarction
26. 2+ exchanger in end-stage human heart failure